Solid phase synthesis of biologically active antigenic peptides for T-cells

Peptides ◽  
1988 ◽  
pp. 524-526
Author(s):  
Lisa A. Casten ◽  
Pravin Kaumaya ◽  
Mark S. Anderson ◽  
John A. Smith ◽  
Susan K. Pierce
1986 ◽  
Vol 140 (2) ◽  
pp. 565-573 ◽  
Author(s):  
Pierre Nicolas ◽  
Antoine Delfour ◽  
Hamadi Boussetta ◽  
Alain Morel ◽  
Mohamed Rholam ◽  
...  

2009 ◽  
Vol 52 (12) ◽  
pp. 3716-3722 ◽  
Author(s):  
Perla Breccia ◽  
Francesca Angeli ◽  
Ilaria Cerbara ◽  
Alessandra Topai ◽  
Giovanni Auricchio ◽  
...  

1988 ◽  
Vol 53 (11) ◽  
pp. 2791-2800 ◽  
Author(s):  
Susumu Funakoshi ◽  
Eigoro Murayama ◽  
Lili Guo ◽  
Nobutaka Fujii ◽  
Haruaki Yajima

Usefulness of a dimethoxybenzhydrylamine derivative, 3-(3-(Fmoc-amino-4-methoxyphenylmethyl)-4-methoxyphenyl)propionic acid, for Fmoc-based solid phase synthesis of peptide amides was demonstrated by preparation of three biologically active peptide amides, i.e. tetragastrin, neuromedin B and [8-arginine]vasopressin. 1M trimethylsilyl bromide-thioanisole (molar ratio 1 : 1) in trifluoroacetic acid was recommended as a deprotecting reagent for releasing the peptide amides from the resin.


Peptides 1990 ◽  
1991 ◽  
pp. 432-433
Author(s):  
F. Rabanal ◽  
I. Haro ◽  
M. A. Busquets ◽  
F. Reig ◽  
J. M. García-Antón

Sign in / Sign up

Export Citation Format

Share Document